| Bluebonnet Dental Care - Main | |
|
4451 Bluebonnet Blvd Suite A Baton Rouge AL 70809 | |
| (225) 767-2273 | |
| (225) 769-3395 |
| Full Name | Bluebonnet Dental Care - Main |
|---|---|
| Speciality | Dentist - General Practice |
| Location | 4451 Bluebonnet Blvd, Baton Rouge, Alabama |
| Authorized Official Name and Position | Jessica Britt (CREDENTIALING COORDINATOR) |
| Authorized Official Contact | 2175408426 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Bluebonnet Dental Care - Main 4451 Bluebonnet Blvd Suite A Baton Rouge AL 70809 Ph: (225) 767-2273 | Bluebonnet Dental Care - Main 4451 Bluebonnet Blvd Suite A Baton Rouge AL 70809 Ph: (225) 767-2273 |
| NPI Number | 1942542766 |
|---|---|
| Provider Enumeration Date | 03/19/2013 |
| Last Update Date | 09/13/2018 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942542766 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | (* (Not Available)) | Primary |
News Archive
Hothead Technologies has executed an agreement with Shafer Medical Devices, a Division of Shafer Enterprises, LLC to develop and distribute a medical application of the H.O.T.™ System that supports the Shafer Medical Devices Hypo/Hyperthermic Pad in managing normothermia in patients, during pre-op, surgery, and post op.
A study published today in The Journal of Pediatrics suggests that early-onset pancreatitis in children is strongly associated with certain genetic mutations and family history of pancreatitis.
A retrospective analysis, conducted at a large infertility clinic between January 2003 and December 2008, demonstrated that there were no significant differences in pregnancy outcomes with three different progesterone formulations for women aged 35 to 40 undergoing in vitro fertilization-embryo transfer (IVF-ET) procedures. These data were presented at the American Society for Reproductive Medicine (ASRM) annual meeting in Atlanta.
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company is in the process of submitting three patent applications for medical safety devices.
A team of investigators headed by International AIDS Vaccine Initiative Investigator Pascal Poignard has been awarded a major grant from the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health to investigate the biological mechanisms underlying the generation of broadly neutralizing antibodies by HIV positive individuals.
› Verified 9 days ago